# Prelude Trust

> Prelude Trust is a VC fund in London backing Health Care, Software and Biotechnology. See 14 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 14
- Last investment: Oct 2007
- Lead investor: 21%
- Last updated: Aug 2026

Prelude Trust is a VC fund in London focused on Health Care and Software. Prelude Trust plc specializes in investments in early stage technology-based businesses. The fund invests in companies primarily based in the United Kingdom.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 21% |
| Software | 2 | 14% |
| Biotechnology | 2 | 14% |
| Semiconductor | 2 | 14% |
| B2B | 1 | 7% |

23 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 5 | 36% |
| Funding Round | 4 | 29% |
| Series C | 2 | 14% |
| Series A | 1 | 7% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 6 | 43% |
| United States | 2 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Oxford Immunotec | Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed toreplace the century old Mantoux skin test ( TST ). | $40M | Series C | Oct 29, 2007 |  |
| XMOS | In 2005, a small team assembled to create a fast and flexible microcontroller that would enable designers to respond quickly to diversifying market demand. The first (XS1) and second (xcore-200) generation processors put unprecedented I/O capability (available through software for the first time) alongside significant DSP and controlprocessing – establishing XMOS as a name in the audio sector.The vision quickly shifted towards AI. Caught between two very different technical and commercial models, Graphcore was formed to focus on server-side AI, and XMOS continued the quest towards low-cost embedded intelligence (edge-AI). Most recently XMOS enabled voice to become mainstream, releasing the XVF3510 – a disruptive high-performance, low cost far-field 2-mic voice interface. This was followed up with xcore.ai – a new crossover processor for the AIoT that brings AI, DSP, control and I/O together in a single device. | $16M | Series B | Sep 06, 2007 |  |
| Tribold | Tribold is the world’s leading provider of Enterprise Product Management (EPM) software specifically developed for Communication Service Providers (CSPs). Tribold EPM™ is a single, integrated suite of Enterprise Product Management applications that empowers CSPs to put products at the heart of their business.Tribold EPM™ is based on aCentralized Product & Service Catalog (CPC) and a Product & Service Lifecycle Management (PLM) solution. Dramatic improvements in product management performance enable CSPs to drive increased profit by reducing time to market, decreased cost to market, increased quality of the product management process and increased ability to support product and service innovation.Today, Tribold EPM manages over US$64b of products and services for our customers. Headquartered in London, and with offices in North America and Asia, Tribold was founded in 2003 and is privately held. | $15M | Series B | Mar 22, 2007 |  |
| Lime Microsystems | Lime Microsystems is a fabless semiconductor company specializing in digitally configurable transceivers for the next generation of wireless broadband systems. | $343K |  | Sep 01, 2006 |  |
| ZBD Displays | ZBD is a leader in the design and supply of the next generation of electronic shelf edge labelling (ESL) - epaper for retail - and associated software solutions for the retail industry. The company blends strategic vision and commercial focus with world-class scientific, engineering and manufacturing expertise. | $5.4M |  | Aug 30, 2006 |  |
| Sciona | Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offersgenetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado. | $9.9M | Series C | Apr 03, 2006 |  |
| m-spatial | As of January 20, 2009, m-spatial ltd. was acquired by mxData Ltd. m-spatial ltd. operates as a local search company for mobile operators, directory service providers, and personal navigation providers. It offers Local Search & Share, which offers a customized Web/mobile local search and share service for branding; Spacemark, whichencapsulates various local search and share in a consumer facing service; and Local Search & Discovery Engine for brands with existing applications offering access to local information via Web, mobile or satnav. m-spatial ltd. was founded in 2000 and is based in Cambridge, the United Kingdom. The company serves the United Kingdom, Germany, Italy, and the Netherlands markets. | $1.6M |  | Feb 28, 2006 |  |
| m-spatial | As of January 20, 2009, m-spatial ltd. was acquired by mxData Ltd. m-spatial ltd. operates as a local search company for mobile operators, directory service providers, and personal navigation providers. It offers Local Search & Share, which offers a customized Web/mobile local search and share service for branding; Spacemark, whichencapsulates various local search and share in a consumer facing service; and Local Search & Discovery Engine for brands with existing applications offering access to local information via Web, mobile or satnav. m-spatial ltd. was founded in 2000 and is based in Cambridge, the United Kingdom. The company serves the United Kingdom, Germany, Italy, and the Netherlands markets. | $1.8M |  | Nov 10, 2005 |  |
| ZBD Displays | ZBD is a leader in the design and supply of the next generation of electronic shelf edge labelling (ESL) - epaper for retail - and associated software solutions for the retail industry. The company blends strategic vision and commercial focus with world-class scientific, engineering and manufacturing expertise. | $4.7M |  | Oct 01, 2005 |  |
| Polatis | Polatis is a provider of optical switching technology. Founded in 2005 as the merger of leading optical technology companies from Cambridge Massachusetts and Cambridge UK, Polatis combined products, technologies and resources to create new solutions for modern fiber-based networks. | $1.1M |  | Jul 29, 2005 |  |

10 of 14 investments shown.

## Co-investors
- [Molten Ventures](https://shizune.co/investors/profile/draper-esprit) — VC Fund, 4 deals together
- [Avlar BioVentures](https://shizune.co/investors/profile/avlar-bioventures) — VC Fund, 2 deals together
- [BASF Venture Capital](https://shizune.co/investors/profile/basf-venture-capital) — VC Fund, 2 deals together
- [Burrill & Company](https://shizune.co/investors/profile/burrill-co) — VC Fund, 2 deals together
- [Delta Partners](https://shizune.co/investors/profile/delta-partners) — VC Fund, 2 deals together
- [DSM Venturing](https://shizune.co/investors/profile/dsm-venturing) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Prelude Trust invest in?

Prelude Trust invests primarily in Health Care, Software and Biotechnology startups, most often at Series B and Funding Round stage. Most of the 14 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Prelude Trust last invest?

The most recent investment recorded for Prelude Trust closed in Oct 2007. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co